SITAGLIPTIN PHOSPHATE 50mg. IP

An antihyperglycemic medication used in the treatment of type 2 diabetes. An adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Effectively prevents serious complications of diabetes like kidney damage and blindness. Provides a new treatment option for patients with type 2 diabetes. (Tina Zerilli, 2007) An effective candidate that lowers HbA1c, and fasting as well as postprandial glucose in monotherapy and in combination with other oral antidiabetic agents. (Gallwitz, 2007) An additional armamentarium in the fight against diabetes. (Seyoum, 2011) A safe, well-tolerated, and effective agent for the treatment of type 2 diabetes. (Gallwitz, 2007) A beneficial treatment option for patients with type 2 diabetes, with potential advantages of weight-neutral effect and a low risk of hypoglycemia. (Dhillon, 2010) An excellent option for monotherapy or combined with metformin, glitazones, or even sulfonylurea. (Juan José Gagliardino, 2008)